Odonate Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 33.528 million compared to USD 29.236 million a year ago. Net loss was USD 33.424 million compared to USD 28.702 million a year ago. Basic loss per share from continuing operations was USD 1.09 compared to USD 1.15 a year ago. For the half year, operating loss was USD 64.349 million compared to USD 58.458 million a year ago. Net loss was USD 63.587 million compared to USD 57.347 million a year ago. Basic loss per share from continuing operations was USD 2.07 compared to USD 2.31 a year ago.